Mp04-15 multi-region sampling of localized renal cell carcinoma tumors demonstrates pd-l1 expression heterogeneity and prognostic ability to identify risk of metastatic progression

The Journal of Urology(2023)

引用 0|浏览3
暂无评分
摘要
You have accessJournal of UrologyCME1 Apr 2023MP04-15 MULTI-REGION SAMPLING OF LOCALIZED RENAL CELL CARCINOMA TUMORS DEMONSTRATES PD-L1 EXPRESSION HETEROGENEITY AND PROGNOSTIC ABILITY TO IDENTIFY RISK OF METASTATIC PROGRESSION Daniel Shapiro, Israa Laklouk, Moon Hee Lee, David Jarrard, Tudor Borza, Glenn Allen, Kyle Richards, Wei Huang, and E. Jason Abel Daniel ShapiroDaniel Shapiro More articles by this author , Israa LakloukIsraa Laklouk More articles by this author , Moon Hee LeeMoon Hee Lee More articles by this author , David JarrardDavid Jarrard More articles by this author , Tudor BorzaTudor Borza More articles by this author , Glenn AllenGlenn Allen More articles by this author , Kyle RichardsKyle Richards More articles by this author , Wei HuangWei Huang More articles by this author , and E. Jason AbelE. Jason Abel More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003215.15AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Prior studies have evaluated PD-L1 expression as a prognostic biomarker for renal cell carcinoma (RCC) with mixed results when sampling only one region of large, heterogeneous tumors. The purpose of this study was to investigate PD-L1 expression using multi-region sampling to evaluate intra-tumor heterogeneity and ability to predict metastatic progression following radical nephrectomy for localized disease. METHODS: RCC tumor tissue microarrays (TMAs) were constructed for non-metastatic RCC patients treated with nephrectomy. Two cohorts of patients were selected, those that progressed to metastatic disease and those that did not. The cohorts were matched for age, gender, performance status, pT-stage, grade, tumor diameter and presence of tumor thrombus. From each tumor, a minimum of 10 tissue cores were analyzed. PD-L1 tissue expression was quantified as optical density (OD) per unit area using the Vectra system and InForm software (version 2.4). PD-L1 expression heterogeneity was evaluated with Kernel-density plots and compared between patients who progressed to metastatic RCC vs patients who remained disease free using nested t-tests. RESULTS: TMAs were constructed for 46 patients. There were no differences in matching characteristics between groups. Metastatic progression was identified in 26 patients with median follow-up of 7 years (IQR 5-11). Twenty patients remained disease free with median follow-up of 11 years (IQR 8-15). Median tumor size was 9 cm in both cohorts (p=0.2). Kernel-density plots demonstrated greater variance in PD-L1 expression among recurrent tumors (Figure 1A). Mean and standard deviation of the PD-L1 OD was higher for recurrent patients (mean OD 0.025 vs 0.011, p<0.001) (Figure 1B). When stratified by median PD-L1 OD, the median recurrence free survival for high PD-L1 expressing tumors was 11.7 months and was not reached for low PD-L1 expressing tumors (p<0.001) (Figure 1C). CONCLUSIONS: PD-L1 expression varies substantially throughout individual tumors. Multi-region sampling helps account for PD-L1 tumor heterogeneity, and PD-L1 expression predicted metastatic progression following radical nephrectomy for localized disease. Further studies are required to validate these findings. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e39 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Daniel Shapiro More articles by this author Israa Laklouk More articles by this author Moon Hee Lee More articles by this author David Jarrard More articles by this author Tudor Borza More articles by this author Glenn Allen More articles by this author Kyle Richards More articles by this author Wei Huang More articles by this author E. Jason Abel More articles by this author Expand All Advertisement PDF downloadLoading ...
更多
查看译文
关键词
renal cell carcinoma,cell carcinoma,multi-region
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要